key: cord-0720302-zwac20vn
authors: Ho, Yolanda I; Wong, Ann H.; Tang, Kevin P. S.; Wong, River C. W.; Leung, Eddie C. M.; Lai, Raymond W. M.
title: Comparison of three commercial SARS‐CoV‐2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics
date: 2021-01-11
journal: J Med Virol
DOI: 10.1002/jmv.26764
sha: ce6d37a976466e660d409d702fe5a334d66abf88
doc_id: 720302
cord_uid: zwac20vn

nan

Comparison of three commercial SARS-CoV-2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics Sample pooling protocol for PF assay on its validated specimen types has recently been approved by FDA 7 and pool testing with the Xpert Xpress SARS-CoV-2 assay on NP swab has also been reported. 8, 9 However, the performance of all three assays on pooled DTS has not been reported and was therefore compared in this study.

From July 31, 2020 to August 7, 2020, 11 positive DTS received from patients attending GOPC were detected with our routine LightMix E-gene assay. All DTS tested in this study were pretreated with methods stated earlier. 4 Using a pool size of 5 as (Table 1) . For the PF assay which targeted at ORF 1ab, the weak positive sample in pool 4 was tested negative but SARS-CoV-2 RNA in the original sample was detected with C t = 35.6 ( Table 1) . The theoretical C t shift (ΔC t ) is Log 2 (n) for a pool size of n. 6 ΔC t of most of the pools tested with the LigthtMix E-gene and the Xpert Xpress assay were close to this expected shift of 2.3 with mean ΔCt = 2.16 and 2.5, respectively ( Table 1 ). The ΔC t was up to 5.06 and 4.9 for the LightMix E-gene and Xpert Xpress assay respectively (Table 1) . Such findings were comparable with those reported by others who had tested on NP samples. [8] [9] [10] [11] Interesting results were observed for the PF assay.

It showed great variation in ΔC t (up to 8.5, Table 1) would lead to more accurate aspiration, and, hence, a lower Ct in the pool. To further investigate specimen matrix related variability, we applied the same pooling protocol to test three positive NP specimens. PF assay Ct of these samples were 19.9, 25.2, and 34.5, respectively. ΔCt variability was much lower (−0.1, 2.9, and 3.6, respectively) and agreed with those reported by Das et al. 12 Precision of each assay for pooled DTS testing was not tested as sample volume was inadequate. According to the manufacturer, the sample in the lysis tube is stable at 2-8°C for 3 months. When samples in the PF lysis tube stored at this temperature range were retested, results were reproducible.

T A B L E 1 Comparison of the original C t for positive DTS tested with three commercial platforms with their corresponding C t in pooled samples Abbreviations: DTS, deep throat saliva; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

Note: Remark: ΔC t = C t of pool − C t of original

Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2

Posterior oropharyngeal saliva for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Saliva is a reliable tool to detect SARS-CoV-2

Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay

Performance evaluation of Panther Fusion SARS-CoV-2 assay for detection of SARS-CoV-2 from deep throat saliva, nasopharyngeal and lower-respiratory-tract specimens

Hologic-Launches-Validated-Pooling-Protocol-for-COVID-19-Testing/ default.aspx

Sample pooling on the Cepheid Xpert Xpress SARS-CoV-2 assay

Recommendations for sample pooling on the Cepheid GeneXpert system using the Cepheid Xpert Xpress SARS-CoV-2 assay

Pooling of samples for testing of SARS-CoV-2 in asymptomatic people

Assessment of specimen pooling to conserve SARS CoV-2 testing resources

Pooled testing for surveillance of SARS-CoV-2 in asymptomatic individuals